Details for Patent: 8,470,368
Summary for Patent: 8,470,368
| Title: | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| Abstract: | A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described. |
| Inventor(s): | Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia |
| Assignee: | Actavis Holdco US Inc |
| Application Number: | US13/151,653 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Device; Dosage form; |
Drugs Protected by US Patent 8,470,368
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,470,368
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 054238 | ⤷ Start Trial | |||
| Australia | 2003272504 | ⤷ Start Trial | |||
| Australia | 2004283059 | ⤷ Start Trial | |||
| Australia | 2006232993 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
